These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 10864664

  • 1. The Rous sarcoma virus long terminal repeat promoter is regulated by TFII-I.
    Mobley CM, Sealy L.
    J Virol; 2000 Jul; 74(14):6511-9. PubMed ID: 10864664
    [Abstract] [Full Text] [Related]

  • 2. Role of the transcription start site core region and transcription factor YY1 in Rous sarcoma virus long terminal repeat promoter activity.
    Mobley CM, Sealy L.
    J Virol; 1998 Aug; 72(8):6592-601. PubMed ID: 9658104
    [Abstract] [Full Text] [Related]

  • 3. Down-regulation of Rous sarcoma virus long terminal repeat promoter activity by a HeLa cell basic protein.
    Yeh CH, Shatkin AJ.
    Proc Natl Acad Sci U S A; 1994 Nov 08; 91(23):11002-6. PubMed ID: 7971997
    [Abstract] [Full Text] [Related]

  • 4. Cloning of Rous sarcoma virus enhancer factor genes. II. RSV-EF-II, abundantly expressed in fibroblasts and muscle tissue, binds to an octamer sequence, 5'-GTACCACC-3', in the noncoding strand of RSV enhancer.
    Cleavinger PJ, Shin BA, Kandala JC, Nambiar A, Swamynathan SK, Guntaka RV.
    Virology; 1996 Aug 01; 222(1):133-43. PubMed ID: 8806494
    [Abstract] [Full Text] [Related]

  • 5. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
    Bowers WJ, Baglia LA, Ruddel A.
    J Virol; 1996 May 01; 70(5):3051-9. PubMed ID: 8627783
    [Abstract] [Full Text] [Related]

  • 6. The human KDR/flk-1 gene contains a functional initiator element that is bound and transactivated by TFII-I.
    Wu Y, Patterson C.
    J Biol Chem; 1999 Jan 29; 274(5):3207-14. PubMed ID: 9915861
    [Abstract] [Full Text] [Related]

  • 7. Accurate positioning of RNA polymerase II on a natural TATA-less promoter is independent of TATA-binding-protein-associated factors and initiator-binding proteins.
    Weis L, Reinberg D.
    Mol Cell Biol; 1997 Jun 29; 17(6):2973-84. PubMed ID: 9154795
    [Abstract] [Full Text] [Related]

  • 8. Human Müllerian-inhibiting substance promoter contains a functional TFII-I-binding initiator.
    Morikawa N, Clarke TR, Novina CD, Watanabe K, Haqq C, Weiss M, Roy AL, Donahoe PK.
    Biol Reprod; 2000 Oct 29; 63(4):1075-83. PubMed ID: 10993829
    [Abstract] [Full Text] [Related]

  • 9. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
    Banders UT, Coussens PM.
    Virology; 1994 Feb 15; 199(1):1-10. PubMed ID: 8116231
    [Abstract] [Full Text] [Related]

  • 10. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity.
    Furlong EE, Rein T, Martin F.
    Mol Cell Biol; 1996 Oct 15; 16(10):5933-45. PubMed ID: 8816507
    [Abstract] [Full Text] [Related]

  • 11. YY1 is a positive regulator of transcription of the Col1a1 gene.
    Riquet FB, Tan L, Choy BK, Osaki M, Karsenty G, Osborne TF, Auron PE, Goldring MB.
    J Biol Chem; 2001 Oct 19; 276(42):38665-72. PubMed ID: 11514536
    [Abstract] [Full Text] [Related]

  • 12. Two leaky-late HSV-1 promoters differ significantly in structural architecture.
    Lieu PT, Wagner EK.
    Virology; 2000 Jun 20; 272(1):191-203. PubMed ID: 10873762
    [Abstract] [Full Text] [Related]

  • 13. Chicken YB-2, a Y-box protein, is a potent activator of Rous sarcoma virus long terminal repeat-driven transcription in avian fibroblasts.
    Swamynathan SK, Nambiar A, Guntaka RV.
    J Virol; 1997 Apr 20; 71(4):2873-80. PubMed ID: 9060644
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional activity of the Rous sarcoma virus long terminal repeat correlates with binding of a factor to an upstream CCAAT box in vitro.
    Greuel BT, Sealy L, Majors JE.
    Virology; 1990 Jul 20; 177(1):33-43. PubMed ID: 2162108
    [Abstract] [Full Text] [Related]

  • 15. Identification of a third protein factor which binds to the Rous sarcoma virus LTR enhancer: possible homology with the serum response factor.
    Boulden A, Sealy L.
    Virology; 1990 Jan 20; 174(1):204-16. PubMed ID: 2152992
    [Abstract] [Full Text] [Related]

  • 16. Identification of EFIV, a stable factor present in many avian cell types that transactivates sequences in the 5' portion of the Rous sarcoma virus long terminal repeat enhancer.
    Houtz EK, Conklin KF.
    J Virol; 1996 Jan 20; 70(1):393-401. PubMed ID: 8523553
    [Abstract] [Full Text] [Related]

  • 17. Identification of a DNA binding site for the nuclear factor YY1 in the human GM-CSF core promoter.
    Ye J, Young HA, Ortaldo JR, Ghosh P.
    Nucleic Acids Res; 1994 Dec 25; 22(25):5672-8. PubMed ID: 7838721
    [Abstract] [Full Text] [Related]

  • 18. Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus.
    Eichbaum QG, Iyer R, Raveh DP, Mathieu C, Ezekowitz RA.
    J Exp Med; 1994 Jun 01; 179(6):1985-96. PubMed ID: 8195721
    [Abstract] [Full Text] [Related]

  • 19. Interaction of the transcription start site core region and transcription factor YY1 determine ascorbate transporter SVCT2 exon 1a promoter activity.
    Qiao H, May JM.
    PLoS One; 2012 Jun 01; 7(4):e35746. PubMed ID: 22532872
    [Abstract] [Full Text] [Related]

  • 20. Transcription factor YY1 is a vaccinia virus late promoter activator.
    Broyles SS, Liu X, Zhu M, Kremer M.
    J Biol Chem; 1999 Dec 10; 274(50):35662-7. PubMed ID: 10585445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.